Evaluation of axillary status in breast cancer. CT-based determination of sentinel lymph node size

Acta Radiol. 2002 Nov;43(6):579-86. doi: 10.1080/j.1600-0455.2002.430608.x.

Abstract

Purpose: To determine whether the location and size of sentinel lymph nodes (SLN) on CT are predictive of the axillary lymph node status in patients with breast cancer.

Material and methods: Forty patients with confirmed breast cancer underwent 5-mm CT of both breasts and axillae and the most inferior lymph node in the affected axilla was designated the SLN. Based on CT assessment of the axillary lymph node status, 22 (55%) patients then underwent dye- and gamma probe (DGP)-guided SLN biopsy followed by axillary dissection; 18 (45%) underwent dissection without prior SLN biopsy. The localization and status of the SLN determined on CT and by DGP-guided biopsy were compared. Biopsied and excised nodes were subjected to histopathologic examinations.

Results: All SLN identified on CT were close to the lateral thoracic artery and their localization corresponded well with SLN identified by the DGP-guided method. The positive predictive value of CT diagnosis was 100%. Histopathologic examination of excised nodes confirmed that none of the SLN biopsies was false-negative.

Conclusion: Our CT criteria were highly accurate for identification and diagnostic assessment of SLN and useful for evaluating the axillary status in patients with breast cancer.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Axilla
  • Breast Neoplasms / pathology*
  • Carcinoma / diagnostic imaging
  • Carcinoma / pathology
  • Carcinoma / secondary*
  • Coloring Agents
  • Female
  • Humans
  • Lymph Node Excision
  • Lymph Nodes / diagnostic imaging*
  • Lymphatic Metastasis
  • Methylene Blue
  • Middle Aged
  • Palpation
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sentinel Lymph Node Biopsy*
  • Tomography, X-Ray Computed*

Substances

  • Coloring Agents
  • Methylene Blue